Steven Cohen's ADPT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 203,075 shares of Adaptive Biotechnologies Corporation (ADPT) worth $3.3 M, representing 0.00% of the portfolio. First purchased in 2019-Q2, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in ADPT, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 5.71 M shares. Largest reduction occurred in Q1 2024, reducing 3.45 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Adaptive Biotechnologies Corporation (ADPT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Adaptive Biotechnologies Corporation (ADPT) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -116,396 | Reduce 36.43% | 203,075 | $16.24 |
| Q3 2025 | -1.05 M | Reduce 76.75% | 319,471 | $14.96 |
| Q2 2025 | +1.37 M | New Buy | 1.37 M | $11.65 |
| Q1 2025 | -937,331 | Sold Out | 0 | $0.00 |
| Q4 2024 | +441,839 | Add 89.17% | 937,331 | $6.00 |
| Q3 2024 | +495,492 | New Buy | 495,492 | $5.12 |
| Q2 2024 | -274,700 | Sold Out | 0 | $0.00 |
| Q1 2024 | -3.45 M | Reduce 92.62% | 274,700 | $3.21 |
| Q4 2023 | -1.99 M | Reduce 34.85% | 3.72 M | $4.90 |
| Q3 2023 | +5.71 M | New Buy | 5.71 M | $5.45 |
| Q3 2019 | -50,000 | Sold Out | 0 | $0.00 |
| Q2 2019 | +50,000 | New Buy | 50,000 | $48.30 |
Steven Cohen's Adaptive Biotechnologies Corporation Investment FAQs
Steven Cohen first purchased Adaptive Biotechnologies Corporation (ADPT) in Q2 2019, acquiring 50,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Adaptive Biotechnologies Corporation (ADPT) for 12 quarters since Q2 2019.
Steven Cohen's largest addition to Adaptive Biotechnologies Corporation (ADPT) was in Q3 2023, adding 5,713,300 shares worth $31.14 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 203,075 shares of Adaptive Biotechnologies Corporation (ADPT), valued at approximately $3.3 M.
As of the Q4 2025 filing, Adaptive Biotechnologies Corporation (ADPT) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Adaptive Biotechnologies Corporation (ADPT) was 5,713,300 shares, as reported at the end of Q3 2023.